Solas BioVentures — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
BiotechHouston, US
Ronald DePinho(Director)David J. Tweardy(Executive Officer, Director)
Chapel Hill, US
Board seatTravis Manasco· per SEC Form D · $4M raise · filed Oct 2021
Francis Medical develops the Vanquish procedure, a medical device treatment for benign prostatic hyperplasia that uses radiofrequency energy to ablate prostate tissue.
Digital HealthHealthtechMedical DevicesMaple Grove, US
Michael Hoey(Director)Michael Kujak(Executive Officer, Director)
BoardAndrew Cleeland(Director)Jan Garfinkle(Director)David Adair(Director)Andre de Bruin(Director)
Board seatMichael Hoey· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.